Featured Abstracts and Author Insights

---

ACG 2022 Newsworthy Abstracts Highlight Cutting-Edge Clinical GI Science

All research presented at ACG 2022 is strictly embargoed until 12:00 pm EDT on Sunday, October 23, 2022.

This page is a gateway to explore the clinical GI science featured at the 2022 ACG Annual Scientific Meeting. Here you will find award-winning abstracts, commentary and perspective from select authors of newsworthy findings, and tips to navigate the array of clinical research being presented at ACG 2022 by investigators working to advance digestive health and improve patient care.

The authors of ACG’s Newsworthy Abstracts, selected by the ACG Public Relations Committee, provide additional perspective on their findings and explain what the clinical science means for patients. Following the links below, reporters can explore these Newsworthy Abstracts and author insights and connect with these researchers for media stories.

To review all ACG Press Releases, visit Media Statements.

• ACG 2022 Conference Platform
  • Tip: the online Conference Platform will allow you to search all abstracts and access the full text for both Plenary and poster presentations.
• Award-Winning Abstracts
  • ACG’s Presidential Posters are highly meritorious projects selected by the Educational Affairs Committee. Look at pages 4-7 for all Abstract Award recipients. Look at pages 8-12 for the Presidential Poster Award recipients.
• Newsworthy Abstracts
  • Explore some of the papers and presentations below, selected by reviewers from ACG’s Educational Affairs and Public Relations Committees, a distinguished group of experts who suggested papers and posters with innovative, newsworthy, and/or significant findings.

Nominated by the ACG Public Relations Committee, this group of abstracts features scientific findings that are innovative, newsworthy for the lay reader, relevant to those who suffer from common GI problems, and which represent a significant advancement in the diagnosis and treatment of GI diseases. The Committee aims to identify novel and thought-provoking abstracts which reinforce key public health messages, discuss emerging research that could inform and improve patient care (particularly for minority and at-risk populations), or which feature common GI problems in a new way.

Newsworthy Abstracts

= ACG Award Winner

• Oral 11 Dupilumab Improves Clinical, Symptomatic, Histologic, and Endoscopic Aspects of EoE up to 24 Weeks: Pooled Results From Parts A and B of Phase 3 LIBERTY-EoE-TREET; Evan Dellon, MD, MPH 
• Oral 15 App-Delivered Gut-Directed Hypnotherapy Program Nerva Improves Symptoms in Patients With Irritable Bowel Syndrome but How Can We Ensure Users Are Compliant?; Simone Peters, PhD
• Oral 18 Predictors of Pancreatitis on Initiation of GLP-1 Receptor Agonists for Weight Loss; Robert Postlethwaite, MD
• Oral 31 Endoscopic Sleeve Gastroplasty vs Intragastric Balloon: A Large, Database Analysis of Early Safety and Efficacy; Anuragh Gudur, MD
• Oral 43 Maternal and Neonatal Outcomes in Vedolizumab and Ustekinumab Exposed Pregnancies: Results From the PIANO Registry; Rishika Chugh, MD
• Oral 55 Clinical Application of Circulating Tumor DNA in Gastrointestinal Cancer Patients; Apaar Dadlani, MBBS
• Oral 63 An Open-Label Study (ECOSPOR IV) to Evaluate the Safety, Efficacy and Durability of SER-109, an Investigational Oral Microbiome Therapeutic, in Adults With Recurrent Clostridioides difficile Infection (rCDI); Sahil Khanna, MBBS, MS, FACG
• Oral 65 The Global Landscape of Nonalcoholic Fatty Liver Disease: Results From the Global Burden of Disease Study, 1990-2019; Yichen Wang, MD  
• Oral 66 Bariatric Surgery Reduces the Risk of Major Liver and Renal Outcomes in Patients With Nonalcoholic Fatty Liver Disease: A Large Population-Based Multicenter Study; Arunkumar Krishnan, MBBS
• A0164 Utilization of Patient-Centered Digital Tools to Improve Adherence Rates for Outpatient Screening Colonoscopies in a Metropolitan Hospital; Iqra Arshad, MD
• A0360 Hospitalization and Surgery Rates in Patients Awaiting Approval of Biologics or Small Molecules for Treating Inflammatory Bowel Disease (IBD); Sarah Glover, DO
• A0370 Racial Disparities in Utilization of Medications in Inflammatory Bowel Disease Patients; Khaled Alsabbagh Alchirazi, MD
• B0268 Rising Inpatient Utilization and Costs of Cannabis Hyperemesis Syndrome Hospitalizations in Massachusetts Following Cannabis Legalization; Allison Marshall, BS
• B0273 TikTok and Irritable Bowel Syndrome (IBS): A Cross-Sectional Study of Social Media Content Quality; Faraz Jafri, BS
• B0516 Quantifying the Negative Impact of Fast-Food Consumption on Liver Steatosis Among U.S. Adults in the General Population; Ani Kardashian, MD
• C0498 Financial Incentives Associated With Hepatitis B Misinformation on Instagram; Zachary C. Warner, MD, MPH
• D0209 Voice Enabled Artificial Intelligence for Detection of Pathologic Gastroesophageal Reflux Disease and Barrett’s Esophagus; Amrit K. Kamboj, MD
• D0302 Hospital Outcomes in Patients With Gastrointestinal Bleeding on Primary Prevention Aspirin: A Nationwide Emergency Department Sample Analysis & D0302 Hospital Outcomes in Patients With Gastrointestinal Bleeding on Primary Prevention Aspirin: A Nationwide Emergency Department Sample Analysis; Darrick K. Li, MD, PhD
• D0403 Social Determinants of Health in LGBTQIA+ Patients With Inflammatory Bowel Disease; Wissam Ghusn, MD
• D0614 Prior Bariatric Surgery and Labor/Delivery and Pregnancy Complications; Shahroz Fatima, MD
• D0624 How Type of Office Visit Influences Attitudes and Preferences for Telemedicine; Andrew Chang, MD
• E0381 A Diet High in Fruits and Vegetables During Biologic Induction May Improve Response to Biologics in Patients With Inflammatory Bowel Disease; Andres D. Rodriguez, DO, MBA

Presidential Plenary
• Oral 1 Benefits of High versus Low Dose Upadacitinib as Maintenance Treatment in Ulcerative Colitis Patients Who Were Responders to 8-week Induction with Upadacitinib: Results From the U-ACHIEVE Phase 3 Maintenance Trial; Brian G. Feagan, MD (No Author Insights Provided) 
• Oral 2 Comparison of Baveno VI Criteria, Expanded Baveno VI Criteria, Chess Alarm Score and Other Noninvasive Scores for Predicting Esophageal Varices and Varices Needing Treatment; Nimy John, MD  
• Oral 3 Virtual Reality Improves Symptoms of Functional Dyspepsia: Results of a Randomized, Controlled, Double-Blind Pilot Study; David Cangemi, MD  
• Oral 4 Results of First Round of Enrollment from the Screening for Pancreatic Cancer in High-Risk Individuals (Pancreas Scan Study): A Prospective Multi-Center Study; Andy Silva-Santisteban, MD  
• Oral 5 High 1-Year Survival Rate of Unresectable Pancreatic Cancer Size Smaller Than 4 cm in Diameter Treated With Concurrent EUS-RFA: An Average Treatment Effect on the Treated Weighted Survival Analysis; Pradermchai Kongkam, MD  
• Oral 6 Endoscopic vs Conservative Treatment for Bleeding Peptic Ulcer With Adherent Clot: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Trials; Azizullah Beran, MD
• Oral 7 High Quality Index Colonoscopies Decrease the Risk for Advanced Outcomes at 10-Year Follow-Up Colonoscopy in Low-Risk Patients With No Index Adenomas or Serrated Polyps; Joseph C. Anderson, MD  
• Oral 8 An Appraisal of the Referral, Uptake and Outcomes of Genetic Counseling and Testing in Patients With Young Onset Colorectal Cancer; Hareem Syed, MD
• Oral 9 Combining Surgical Pyloroplasty and Gastric Electrical Stimulation in Gastroparetic Patients Is Superior to Pyloroplasty Alone: A Randomized Double Blind Placebo Control Trial; Irene Sarosiek, MD  
• Oral 10 An Objective Spatialomics Test Standardizes Management Decisions With Potential to Improve Health Outcomes for Barrett’s Esophagus Patients; Presenter: Lucas Duits, MD, PhD